RecallRadar

FDA Drug recall D-0399-2026

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals…

On 2026-03-11 the FDA classified a Class II recall of Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals… by Mylan Pharmaceuticals, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0399-2026
ClassificationClass II
Statusongoing
Initiated2026-02-24
Published2026-03-11
Last updated2026-09-13 11:52 UTC
CompanyMylan Pharmaceuticals
DistributionUS

Product

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

Reason

Failed Dissolution Specifications

Identifiers

ndc0378-6611-85
ndc0378-6611-93
ndc0378-6612-85
ndc0378-6612-93
ndc0378-6613-85
ndc0378-6613-93
ndc0378-6614-85
ndc0378-6614-93
code_infoLot #: 3116110, 3116130, Exp. Date 07/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0399-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.